Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CW9Q
|
|||
| Drug Name |
PMID28048944-Compound-19
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H16N4O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCNC(=O)NC2=CC3=C(C=C2)NN=C3
|
|||
| InChI |
1S/C16H16N4O/c21-16(17-9-8-12-4-2-1-3-5-12)19-14-6-7-15-13(10-14)11-18-20-15/h1-7,10-11H,8-9H2,(H,18,20)(H2,17,19,21)
|
|||
| InChIKey |
XEZOXLSEWZHMQY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.